{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:00:45Z","timestamp":1777510845255,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T00:00:00Z","timestamp":1263254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10067-009-1340-7","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T12:27:10Z","timestamp":1263212830000},"page":"399-403","source":"Crossref","is-referenced-by-count":69,"title":["Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs"],"prefix":"10.1007","volume":"29","author":[{"given":"Mariangela","family":"Atteno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Padula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Iervolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sanduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Del Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,12]]},"reference":[{"key":"1340_CR1","first-page":"627","volume":"21","author":"V Wright","year":"1971","unstructured":"Wright V, Moll JMH (1971) Psoriatic arthritis. Bull Rheum Dis 21:627\u2013632","journal-title":"Bull Rheum Dis"},{"issue":"12","key":"1340_CR2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","volume":"42","author":"D Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B, FitzGerald O (2003) A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42(12):1460\u20131468","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1340_CR3","first-page":"1422","volume":"33","author":"ER Soriano","year":"2006","unstructured":"Soriano ER, McHugh NJ (2006) Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 33(7):1422\u20131430","journal-title":"J Rheumatol"},{"issue":"1","key":"1340_CR4","first-page":"70","volume":"24","author":"C Salvarani","year":"2006","unstructured":"Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M, Italian Society for Rheumatology (2006) Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis. Clin Exp Rheumatol 24(1):70\u201378","journal-title":"Clin Exp Rheumatol"},{"key":"1340_CR5","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis. Arthritis Rheum 54:2665\u20132673","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1340_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-008-0048-z","volume":"10","author":"K Vlam de","year":"2008","unstructured":"de Vlam K, Lories RJ (2008) Remission in psoriatic arthritis. Curr Rheumatol Rep 10(4):297\u2013302","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"1340_CR7","first-page":"1842","volume":"28","author":"KB Sokoll","year":"2001","unstructured":"Sokoll KB, Helliwell PS (2001) Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 28(8):1842\u20131846","journal-title":"J Rheumatol"},{"issue":"7","key":"1340_CR8","first-page":"1115","volume":"19","author":"D Buskila","year":"1992","unstructured":"Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA (1992) Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 19(7):1115\u20131119","journal-title":"J Rheumatol"},{"issue":"7","key":"1340_CR9","first-page":"1228","volume":"33","author":"D Gladman","year":"2006","unstructured":"Gladman D, Mease PJ (2006) Towards International Guidelines for the management of Psoriatic Arthritis. J Rheumatol 33(7):1228\u20131230","journal-title":"J Rheumatol"},{"issue":"7","key":"1340_CR10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10067-007-0787-7","volume":"27","author":"R Scarpa","year":"2008","unstructured":"Scarpa R, Peluso R, Atteno M, Manguso F, Span\u00f2 A, Iervolino S et al (2008) The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomized 6-month trial with methotrexate. Clin Rheumatol 27(7):823\u2013826","journal-title":"Clin Rheumatol"},{"issue":"10","key":"1340_CR11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ncprheum0880","volume":"4","author":"D Gladman","year":"2008","unstructured":"Gladman D (2008) Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis. Nat Clin Pract Rheum 4(10):510\u2013511","journal-title":"Nat Clin Pract Rheum"},{"issue":"3","key":"1340_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kei153","volume":"45","author":"K Vlam De","year":"2006","unstructured":"De Vlam K (2006) Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study. Rheumatology (Oxford) 45(3):321\u2013324","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1340_CR13","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","volume":"50","author":"PJ Mease","year":"2004","unstructured":"Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P et al (2004) Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50(7):2264\u20132272","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1340_CR14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ard.2007.087270","volume":"68","author":"D Heijde Van der","year":"2009","unstructured":"Van der Heijde D, Schiff MH, Sieper J, Kivitz A, Wong RL, Kupper H et al (2009) Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2\u00a0years: long-term results from the ATLAS trial. Ann Rheum Dis 68(6):922\u2013929, published online 2008 Aug 12","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1340_CR15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, R\u00f8devand E, Holck P, Vanhoof J, Kron M, Kary S et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68(5):696\u2013701","journal-title":"Ann Rheum Dis"},{"key":"1340_CR16","doi-asserted-by":"crossref","unstructured":"Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69(1):48\u201353","DOI":"10.1136\/ard.2008.102053"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1340-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1340-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:38Z","timestamp":1559105498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1340-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,12]]}}}